HHS List of Certified Drug Testing Laboratories Lawsuit

The Department of Health and Human Services published a notice on November 2, 2026, listing the laboratories and Instrumented Initial Testing Facilities currently certified to meet the Mandatory Guidelines for Federal Workplace Drug Testing Programs. The notice covers urine testing by laboratories and Instrumented Initial Testing Facilities, which are facilities that perform initial drug testing on specimens, and oral fluid testing by laboratories. It appears at 91 FR 68964 and carries Federal Register document number 2026-22321.

At a glance

• The notice was published by the Department of Health and Human Services and the Substance Abuse and Mental Health Services Administration on November 2, 2026.
• It is a notice, not a rule, and its stated action is “Notice.”
• The document runs from page 68964 to page 68965 of volume 91 of the Federal Register, a total of 2 pages.
• It lists laboratories and Instrumented Initial Testing Facilities certified under the Mandatory Guidelines for urine testing, and laboratories certified for oral fluid testing.
• The Federal Register assigns the document number 2026-22321 and the citation 91 FR 68964.

What the November 2, 2026 notice does

The Department of Health and Human Services (HHS) used the notice to publish its current list of certified testing entities. According to the abstract, the notice identifies the laboratories and Instrumented Initial Testing Facilities currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs using urine. It also identifies the laboratories currently certified to meet those standards using oral fluid.

The document describes two specimen types, urine and oral fluid, and two categories of testing entity. An Instrumented Initial Testing Facility is a facility that conducts initial testing of specimens using instruments, as distinct from a full laboratory. The notice is published under the authority of HHS, with the Substance Abuse and Mental Health Services Administration listed as a co-agency.

The Federal Register classifies the document as a notice. Its “action” field reads simply “Notice.” No comment period is attached: the comment URL and the comments closing date fields are both empty. No effective date is listed, and the document carries no docket identifiers.

What is established vs. what is alleged

Nothing in this document is alleged. A Federal Register notice is an official publication by the issuing agency, and the statements in it are the agency’s own.

What is established by the document record is narrow and specific. HHS, with the Substance Abuse and Mental Health Services Administration, published a notice on November 2, 2026, at 91 FR 68964, document number 2026-22321. The notice states that it provides the current list of certified laboratories, certified Instrumented Initial Testing Facilities, and certified oral fluid laboratories. The document is 2 pages long, beginning on page 68964 and ending on page 68965 of volume 91.

What the record supplied here does not establish is the contents of the list itself. The abstract describes the categories of entity covered but does not name any laboratory or facility. The full text, the PDF, and the XML versions of the document are hosted separately by the Federal Register and GovInfo, and the names would appear there. Anyone who needs the identity of a specific certified entity has to consult those versions of the document rather than this summary.

Where the listing stands procedurally

This is a publication action by an executive department, not a court proceeding. There is no lawsuit, no multidistrict litigation, and no trial date connected to the notice. No federal court consolidation exists for the subject matter of the document.

The procedural posture is therefore simple. HHS issued the notice, the Office of the Federal Register published it on November 2, 2026, and it took its place in volume 91 of the Federal Register at pages 68964 to 68965. The document is not a correction of an earlier notice; the correction fields in the record are empty, and the document does not itself identify any corrections. It is also not marked as a significant regulatory action, and it carries no regulation identifier numbers.

Because the action is a notice rather than a rule, it does not amend the Mandatory Guidelines. It reports which entities the agency currently recognizes as meeting those guidelines for the specimen types named. The record supplied here does not describe any application, inspection, or review process behind an individual certification.

Key dates

• November 2, 2026: HHS published the notice “Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine and Oral Fluid Drug Testing for Federal Agencies” in the Federal Register as document 2026-22321, at 91 FR 68964.
• October 31, 2026: the regulations.gov information for the document was last checked, according to the Federal Register record.
• November 2, 2026: the Federal Register’s page view counter for the document was last updated, at 61 views.
• November 2, 2026: the document was publicly inspected before publication, per the public inspection PDF record.

What this does not establish

The record supplied here does not list the names of any certified laboratory or Instrumented Initial Testing Facility. It does not state how many entities are certified for urine testing or for oral fluid testing. It does not give the location of any certified entity.

It also does not address certification of any specific test, product, or manufacturer. Nothing in the document speaks to the accuracy or reliability of any particular drug test result, and nothing in it creates rights or obligations for a private employer. The notice concerns the federal workplace drug testing program and the standards set by the Mandatory Guidelines; it does not describe state law, private testing arrangements, or the consequences of a result for any individual.

Finally, the notice is not a safety communication, a recall, a settlement, or a court ruling. It should not be read as any of those things. Related coverage of Food and Drug Administration recalls and product actions, such as the American Health Packaging metoclopramide recall or the J and J Innovative Medicine Imaavy recall, involves a different agency and a different legal mechanism.

Frequently asked questions

What did HHS publish on November 2, 2026?

The Department of Health and Human Services published a Federal Register notice, document number 2026-22321 at 91 FR 68964, listing the laboratories and Instrumented Initial Testing Facilities currently certified to meet the Mandatory Guidelines for Federal Workplace Drug Testing Programs using urine, and the laboratories certified using oral fluid. The Substance Abuse and Mental Health Services Administration is listed as a co-agency. The document is 2 pages long. It is a notice, not a rule.

Does the notice name the certified laboratories?

The notice itself is described by HHS as providing the current list of certified laboratories and Instrumented Initial Testing Facilities. The abstract in the Federal Register record supplied here does not reproduce those names, and the full text is hosted separately as HTML, PDF, and XML versions. A reader who needs the identity of a specific certified entity should open one of those full-text versions published on November 2, 2026.

Is this the same as a drug recall or a lawsuit?

No. The November 2, 2026 document is an HHS notice published in the Federal Register, and it carries no court case, no docket number, and no recall classification. It concerns certification of testing facilities under federal workplace drug testing standards. Product recalls and litigation, such as the matters covered in the site’s GLP-1 litigation overview, are handled by different agencies and different forums.

Can the public comment on the notice?

The Federal Register record for document 2026-22321 shows no comment URL and no closing date for comments. The action is listed as “Notice” rather than a proposed rule, and the document has no regulation identifier number. The record supplied here does not describe any comment process for this publication.

Sources

1. Federal Register: “Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine and Oral Fluid Drug Testing for Federal Agencies” (link, accessed 2026-11-02)
2. Federal Register: “All Documents” (link, accessed 2026-11-02)
3. Federal Register: “Agencies” (link, accessed 2026-11-02)
4. Federal Register: “Documents of type Rule” (link, accessed 2026-11-02)
5. Federal Register: “Documents of type Notice” (link, accessed 2026-11-02)
6. Federal Register: “Documents of type Proposed Rule” (link, accessed 2026-11-02)